|
|
#1
08-25-2016, 10:55 AM
|
|||
|
|||
**vartis an**unces positive phase III results for MS drug siponimod
ZURICH (Reuters) – **vartis AG said a late-stage study showed its oral, once-daily BAF312, or siponimod, reduced the risk of disability progression in a severe form of multiple sclerosis. ??????? ??????: **vartis an**unces positive phase III results for MS drug siponimod || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
